# National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan

> **NCT06149806** · — · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 50 (estimated)

## Conditions studied

- Complex Congenital Heart Disease

## Interventions

- **DRUG:** Sacubitril / Valsartan Oral Tablet [Entresto]

## Key facts

- **NCT ID:** NCT06149806
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06149806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06149806, "National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06149806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*